Na Zhao, Ping Chen, Juan Chen, Baobao Wang, Xueqing Tang, Lijun Tang et al. Obinutuzumab is effective for refractory primary membranous nephropathy. // BMC Nephrology. – 2026. – DOI: 10.1186/s12882-026-05051-4. – URL: https://doi.org/10.1186/s12882-026-05051-4
Na Zhao, Ping Chen, Juan Chen, Baobao Wang, Xueqing Tang, Lijun Tang, Zunsong Wang, & Ying Zhang (2026). Obinutuzumab is effective for refractory primary membranous nephropathy. BMC Nephrology. https://doi.org/10.1186/s12882-026-05051-4
Na Zhao, et al. “Obinutuzumab is effective for refractory primary membranous nephropathy.” BMC Nephrology, 2026. doi:10.1186/s12882-026-05051-4.
@article{Zhao2026,
title = {Obinutuzumab is effective for refractory primary membranous nephropathy},
author = {Zhao, Na and Chen, Ping and Chen, Juan and Wang, Baobao and Tang, Xueqing and Tang, Lijun and Wang, Zunsong and Zhang, Ying},
journal = {BMC Nephrology},
year = {2026},
doi = {10.1186/s12882-026-05051-4},
url = {https://doi.org/10.1186/s12882-026-05051-4}
}